glp-1 in canada 3 million Canadians use drugs. Survey says that's changing their appetites — and habits Safety risks in the GLP-1

They concluded that ALCAR exhibited anti-fibrotic and anti-inflammatory effects in in-vitro and in-vivo models of Peyronie's Disease

The GLP-1 space is evolving rapidly, and the platforms that evolve with itby aligning with pharma, regulators, and patient expectationsare the ones that will thrive

Laboratory research record on GLP-1S [PMID: 36254579] PubMed laboratory record discussing GLP-1S in a research context

If you are already working with a Flow Wellness provider, message them here

Heres how they fit into a comprehensive approach to lasting weight loss: Jumpstarting Weight Loss: GLP-1 therapies help reduce appetite, increase feelings of fullness, and promote fat loss, making it easier for individuals to kickstart their weight loss journey, especially if diet and exercise alone have not been successful